BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 19814948)

  • 1. Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
    Simon NM; Otto MW; Worthington JJ; Hoge EA; Thompson EH; Lebeau RT; Moshier SJ; Zalta AK; Pollack MH
    J Clin Psychiatry; 2009 Nov; 70(11):1563-70. PubMed ID: 19814948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early coadministration of clonazepam with sertraline for panic disorder.
    Goddard AW; Brouette T; Almai A; Jetty P; Woods SW; Charney D
    Arch Gen Psychiatry; 2001 Jul; 58(7):681-6. PubMed ID: 11448376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SECOND-STAGE TREATMENTS FOR RELATIVE NONRESPONDERS TO COGNITIVE BEHAVIORAL THERAPY (CBT) FOR PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA-CONTINUED CBT VERSUS SSRI: A RANDOMIZED CONTROLLED TRIAL.
    Payne LA; White KS; Gallagher MW; Woods SW; Shear MK; Gorman JM; Farchione TJ; Barlow DH
    Depress Anxiety; 2016 May; 33(5):392-9. PubMed ID: 26663632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sertraline treatment of panic disorder: response in patients at risk for poor outcome.
    Pollack MH; Rapaport MH; Clary CM; Mardekian J; Wolkow R
    J Clin Psychiatry; 2000 Dec; 61(12):922-7. PubMed ID: 11206597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone.
    Kampman M; Keijsers GP; Hoogduin CA; Hendriks GJ
    J Clin Psychiatry; 2002 Sep; 63(9):772-7. PubMed ID: 12363116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of cognitive-behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia: treatment results through 1-year follow-up.
    van Apeldoorn FJ; Timmerman ME; Mersch PP; van Hout WJ; Visser S; van Dyck R; den Boer JA
    J Clin Psychiatry; 2010 May; 71(5):574-86. PubMed ID: 20492852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
    Bandelow B; Baldwin DS; Dolberg OT; Andersen HF; Stein DJ
    J Clin Psychiatry; 2006 Sep; 67(9):1428-34. PubMed ID: 17017830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy.
    Simon NM; Connor KM; Lang AJ; Rauch S; Krulewicz S; LeBeau RT; Davidson JR; Stein MB; Otto MW; Foa EB; Pollack MH
    J Clin Psychiatry; 2008 Mar; 69(3):400-5. PubMed ID: 18348595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia.
    van Apeldoorn FJ; van Hout WJ; Mersch PP; Huisman M; Slaap BR; Hale WW; Visser S; van Dyck R; den Boer JA
    Acta Psychiatr Scand; 2008 Apr; 117(4):260-70. PubMed ID: 18307586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate of improvement during and across three treatments for panic disorder with or without agoraphobia: cognitive behavioral therapy, selective serotonin reuptake inhibitor or both combined.
    Van Apeldoorn FJ; Van Hout WJ; Timmerman ME; Mersch PP; den Boer JA
    J Affect Disord; 2013 Sep; 150(2):313-9. PubMed ID: 23676529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder.
    Rothbaum BO; Killeen TK; Davidson JR; Brady KT; Connor KM; Heekin MH
    J Clin Psychiatry; 2008 Apr; 69(4):520-5. PubMed ID: 18278987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and time course of response among panic disorder patients treated with cognitive-behavioral therapy.
    Aaronson CJ; Shear MK; Goetz RR; Allen LB; Barlow DH; White KS; Ray S; Money R; Saksa JR; Woods SW; Gorman JM
    J Clin Psychiatry; 2008 Mar; 69(3):418-24. PubMed ID: 18278989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single modality versus dual modality treatment for trichotillomania: sertraline, behavioral therapy, or both?
    Dougherty DD; Loh R; Jenike MA; Keuthen NJ
    J Clin Psychiatry; 2006 Jul; 67(7):1086-92. PubMed ID: 16889452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder.
    Pollack MH; Rapaport MH; Fayyad R; Otto MW; Nierenberg AA; Clary CM
    J Psychiatr Res; 2002; 36(4):229-36. PubMed ID: 12191627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.
    Pollack MH; Otto MW; Worthington JJ; Manfro GG; Wolkow R
    Arch Gen Psychiatry; 1998 Nov; 55(11):1010-6. PubMed ID: 9819070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine extended release capsules in adult outpatients with panic disorder.
    Liebowitz MR; Asnis G; Mangano R; Tzanis E
    J Clin Psychiatry; 2009 Apr; 70(4):550-61. PubMed ID: 19358784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Prolonged Exposure Therapy, Sertraline Hydrochloride, and Their Combination Among Combat Veterans With Posttraumatic Stress Disorder: A Randomized Clinical Trial.
    Rauch SAM; Kim HM; Powell C; Tuerk PW; Simon NM; Acierno R; Allard CB; Norman SB; Venners MR; Rothbaum BO; Stein MB; Porter K; Martis B; King AP; Liberzon I; Phan KL; Hoge CW
    JAMA Psychiatry; 2019 Feb; 76(2):117-126. PubMed ID: 30516797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.